PET/MRI in Oropharyngeal Squamous Cell Carcinoma Evaluation
Launched by CHANG GUNG MEMORIAL HOSPITAL · May 21, 2017
Trial Information
Current as of April 29, 2025
Unknown status
Keywords
ClinConnect Summary
Introduction and aim of study:
Head and neck cancer (HNC) continues to be a significant health care problem in Taiwan and oropharyngeal squamous cell carcinoma (SCC) is the common subtype. With the concern of organ preservation in recent years, concurrent chemoradiation is the major treatment modality for oropharyngeal SCC. Hence, accurate tumor anatomic and biologic evaluations are warranted for pretreatment planning, posttreatment monitoring and prognosis determination. Endoscopy with biopsy serve as the main diagnostic tools in patients with oropharyngeal SCC. While computed tomography ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • histologically proven oropharyngeal SCC subjected to chemoradiation
- Exclusion Criteria:
- • Exclusion criteria include previous head or neck malignant tumor, a second malignant tumor, distant metastasis, contraindications to MRI (renal insufficiency, cochlear implant, cardiac pacemaker placement or intracranial aneurysmal ferromagnetic clips), and serum glucose level \>200 mg/dl.
About Chang Gung Memorial Hospital
Chang Gung Memorial Hospital, one of the largest healthcare organizations in Taiwan, is renowned for its commitment to advancing medical research and improving patient care. As a clinical trial sponsor, the hospital leverages its extensive clinical expertise and state-of-the-art facilities to conduct innovative research across various medical disciplines. With a focus on collaboration and ethical practices, Chang Gung Memorial Hospital aims to contribute to the global body of medical knowledge through rigorous clinical trials that enhance treatment options and improve health outcomes for patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Gueishan, Taoyuan, Taiwan
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials